Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Lingor

Showing results (121-130 of 173) with videos related to

Pageof 18
Sort By:
Journal of Neurochemistry|June 27, 2021
Brain iron enrichment attenuates α-synuclein spreading after injection of preformed fibrilsKarina Dauer Née Joppe, Lars Tatenhorst, Lucas Caldi Gomes, et al.
Neurological Research and Practice|February 5, 2025
Shared prognostic information in amyotrophic lateral sclerosis - systematic assessment of the patients' perception of neurofilament light chain and the ALS functional rating scaleLukas Maximilian Möhwald, André Maier, Torsten Grehl, et al.
Neurological Research and Practice|December 15, 2022
ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scaleAndré Maier, Matthias Boentert, Peter Reilich, et al.
Journal of Neurochemistry|July 29, 2023
Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 (NPTX1) as synapto-axonal target in late-stage Parkinson's diseaseCarmina C Warth Perez Arias, Ivan Silbern, Lucas Caldi Gomes, et al.
Journal of Neurology|September 26, 2019
Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersenClaudia D Wurster, Petra Steinacker, René Günther, et al.
Brain Sciences|January 21, 2023
Health-Related Quality of Life in Spinal Muscular Atrophy Patients and Their Caregivers-A Prospective, Cross-Sectional, Multi-Center AnalysisCamilla Wohnrade, Ann-Kathrin Velling, Lucas Mix, et al.
Therapeutic Advances in Neurological Disorders|March 22, 2021
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapyAlma Osmanovic, Gresa Ranxha, Mareike Kumpe, et al.
Glia|December 7, 2013
Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosisLars Tönges, Rene Günther, Martin Suhr, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 3, 2021
Challenges and opportunities for Multi-National Investigator-Initiated clinical trials for ALS: European and United States collaborationsPaul Lingor, Jan C Koch, Jeffrey M Statland, et al.
Frontiers in Neurology|December 3, 2019
Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With NusinersenClaudia D Wurster, Jan C Koch, Isabell Cordts, et al.
Pageof 18

Showing results (121-130 of 173) with videos related to

Sort By:
Pageof 18
Journal of Neurochemistry|June 27, 2021
Brain iron enrichment attenuates α-synuclein spreading after injection of preformed fibrilsKarina Dauer Née Joppe, Lars Tatenhorst, Lucas Caldi Gomes, et al.
Neurological Research and Practice|February 5, 2025
Shared prognostic information in amyotrophic lateral sclerosis - systematic assessment of the patients' perception of neurofilament light chain and the ALS functional rating scaleLukas Maximilian Möhwald, André Maier, Torsten Grehl, et al.
Neurological Research and Practice|December 15, 2022
ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scaleAndré Maier, Matthias Boentert, Peter Reilich, et al.
Journal of Neurochemistry|July 29, 2023
Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1 (NPTX1) as synapto-axonal target in late-stage Parkinson's diseaseCarmina C Warth Perez Arias, Ivan Silbern, Lucas Caldi Gomes, et al.
Journal of Neurology|September 26, 2019
Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersenClaudia D Wurster, Petra Steinacker, René Günther, et al.
Brain Sciences|January 21, 2023
Health-Related Quality of Life in Spinal Muscular Atrophy Patients and Their Caregivers-A Prospective, Cross-Sectional, Multi-Center AnalysisCamilla Wohnrade, Ann-Kathrin Velling, Lucas Mix, et al.
Therapeutic Advances in Neurological Disorders|March 22, 2021
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapyAlma Osmanovic, Gresa Ranxha, Mareike Kumpe, et al.
Glia|December 7, 2013
Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosisLars Tönges, Rene Günther, Martin Suhr, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 3, 2021
Challenges and opportunities for Multi-National Investigator-Initiated clinical trials for ALS: European and United States collaborationsPaul Lingor, Jan C Koch, Jeffrey M Statland, et al.
Frontiers in Neurology|December 3, 2019
Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With NusinersenClaudia D Wurster, Jan C Koch, Isabell Cordts, et al.
Pageof 18